Merck nausea drug works
in children in late-stage trial
Send a link to a friend
[June 30, 2014]
(Reuters) - Merck & Co Inc
said its drug for treating chemotherapy-induced nausea
and vomiting, Emend, was shown to be more effective than
a placebo in a late-stage trial in children.
The company said 51 percent of patients getting Emend showed no
vomiting, no retching and no use of rescue medication for nausea and
vomiting 25 to 120 hours following the beginning of chemotherapy,
compared to 26 percent of those on a placebo.
The drug is already approved for treating chemotherapy-induced
nausea and vomiting in adults.
(Reporting by Esha Dey in Bangalore; Editing by Saumyadeb
[to top of second column]
[© 2014 Thomson Reuters. All rights
Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.